Xiaohua Cui

487 total citations
27 papers, 397 citations indexed

About

Xiaohua Cui is a scholar working on Pharmacology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Xiaohua Cui has authored 27 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 5 papers in Molecular Biology. Recurrent topics in Xiaohua Cui's work include Epilepsy research and treatment (6 papers), Bipolar Disorder and Treatment (5 papers) and Schizophrenia research and treatment (5 papers). Xiaohua Cui is often cited by papers focused on Epilepsy research and treatment (6 papers), Bipolar Disorder and Treatment (5 papers) and Schizophrenia research and treatment (5 papers). Xiaohua Cui collaborates with scholars based in China, United States and Hong Kong. Xiaohua Cui's co-authors include Rong Wu, Jianping Gao, Huilin Wang, Xu Xu, Yan Gao, Youping Li, Cheng Lan, Qiang Yuan, Li Wang and Hongcai Shang and has published in prestigious journals such as Journal of Affective Disorders, Sensors and Actuators B Chemical and Clinica Chimica Acta.

In The Last Decade

Xiaohua Cui

25 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohua Cui China 10 148 72 51 46 42 27 397
Mengjie Xiao China 14 280 1.9× 109 1.5× 48 0.9× 35 0.8× 46 1.1× 37 588
Masafumi Funamoto Japan 16 313 2.1× 127 1.8× 30 0.6× 32 0.7× 29 0.7× 61 732
Xi Wu China 9 141 1.0× 62 0.9× 23 0.5× 39 0.8× 37 0.9× 18 352
Jingmeng Sun China 12 211 1.4× 50 0.7× 76 1.5× 63 1.4× 16 0.4× 18 456
Xinghui Wang China 14 209 1.4× 59 0.8× 27 0.5× 21 0.5× 14 0.3× 31 549
Mahmoud El‐Daly Egypt 15 177 1.2× 65 0.9× 52 1.0× 26 0.6× 10 0.2× 40 601
Md Sayeed Akhtar Saudi Arabia 13 156 1.1× 81 1.1× 33 0.6× 39 0.8× 9 0.2× 40 532
Tiantian Xu China 15 248 1.7× 24 0.3× 40 0.8× 31 0.7× 17 0.4× 27 572
Wenjing Li China 11 176 1.2× 66 0.9× 45 0.9× 48 1.0× 7 0.2× 47 471
Wafaa S. Ramadan Saudi Arabia 13 122 0.8× 95 1.3× 15 0.3× 44 1.0× 43 1.0× 34 483

Countries citing papers authored by Xiaohua Cui

Since Specialization
Citations

This map shows the geographic impact of Xiaohua Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohua Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohua Cui more than expected).

Fields of papers citing papers by Xiaohua Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohua Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohua Cui. The network helps show where Xiaohua Cui may publish in the future.

Co-authorship network of co-authors of Xiaohua Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohua Cui. A scholar is included among the top collaborators of Xiaohua Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohua Cui. Xiaohua Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jing, Jianbing Liu, Xiaohua Cui, et al.. (2025). Tubeimoside I induces mitophagy by activating the PINK1/Parkin/Mfn2 signaling pathway in acute myeloid leukemia cells. Translational Oncology. 55. 102355–102355. 2 indexed citations
2.
Ding, Jing, Jiarui Liu, Xiaohua Cui, et al.. (2025). Development of a nomogram risk prediction model for subtherapeutic valproic acid plasma concentration: A retrospective cohort study. Journal of Affective Disorders. 393(Pt B). 120473–120473.
3.
4.
Zhao, Xuhua, Yanan Zhou, Hanxiao Zhang, et al.. (2023). G-quadruplex molecular beacon: A versatile CRISPR/Cas12a reporter for rapid and label-free biosensing. Sensors and Actuators B Chemical. 380. 133310–133310. 20 indexed citations
5.
Wan, Xiaoqing, et al.. (2023). New molecular insights into ferroptosis in lung adenocarcinoma progression and pharmacological compounds for targeted therapy. The Journal of Gene Medicine. 26(1). e3579–e3579. 2 indexed citations
6.
Ding, Jing, Jing Yang, Xiaohua Cui, et al.. (2023). A 5-year retrospective study of amisulpride steady-state plasma concentration in patients with schizophrenia in real-life settings based on therapeutic drug monitoring data. Asian Journal of Psychiatry. 87. 103699–103699. 2 indexed citations
7.
Ding, Jing, et al.. (2023). Therapeutic drug monitoring of perospirone: The lowest effective plasma concentration in patients with schizophrenia. Asian Journal of Psychiatry. 90. 103832–103832. 1 indexed citations
8.
Ding, Jing, Jianfeng Liu, Yang Zhang, et al.. (2023). A retrospective study of clozapine and norclozapine concentration in patients with schizophrenia: Data from the Therapeutic Drug Monitoring Service, 2019–2022. Asian Journal of Psychiatry. 91. 103865–103865. 1 indexed citations
9.
Zhao, Zhenlei, et al.. (2023). Protective effect of mussel polysaccharide on cyclophosphamide‐induced intestinal oxidative stress injury via Nrf2‐Keap1 signaling pathway. Food Science & Nutrition. 11(7). 4233–4245. 8 indexed citations
10.
Ding, Jing, Jing Yang, Yan Zhang, et al.. (2023). Usefulness of Therapeutic Drug Monitoring and Pharmacogenetics for a Patient Treated with Olanzapine, Buspirone, and Fluvoxamine: A Case Study. Therapeutic Drug Monitoring. 45(4). 425–427.
12.
Wu, Rong, Huilin Wang, Yan Gao, et al.. (2018). Effect of fermented Cordyceps�sinensis on doxorubicin‑induced cardiotoxicity in rats. Molecular Medicine Reports. 18(3). 3229–3241. 22 indexed citations
13.
Cui, Xiaohua, et al.. (2016). Quasi-likelihood Bridge estimators for high-dimensional generalized linear models. Communications in Statistics - Simulation and Computation. 46(10). 8190–8204. 1 indexed citations
14.
Gao, Jianping, Rong Wu, Huilin Wang, et al.. (2015). Effects of fermented Cordyceps sinensis on oxidative stress in doxorubicin treated rats. Pharmacognosy Magazine. 11(44). 724–724. 19 indexed citations
15.
Wu, Rong, Huilin Wang, Xiaohua Cui, et al.. (2015). Doxorubicin toxicity changes myocardial energy metabolism in rats. Chemico-Biological Interactions. 244. 149–158. 53 indexed citations
16.
Wang, Huilin, Jianping Gao, Xu Xu, et al.. (2015). Comparative studies of polydatin and resveratrol on mutual transformation and antioxidative effect in vivo. Phytomedicine. 22(5). 553–559. 117 indexed citations
17.
Yang, Xiaoyan, et al.. (2010). Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: A meta-analysis. Journal of Infection. 60(5). 320–330. 22 indexed citations
18.
Wang, Li, Cheng Lan, Qiang Yuan, et al.. (2010). Adverse drug reactions of Shuanghuanglian injection: A systematic review of public literatures. Journal of Evidence-Based Medicine. 3(1). 18–26. 28 indexed citations
20.
Wang, Li, Xiaohua Cui, Cheng Lan, et al.. (2010). Adverse events to Houttuynia injection: A systematic review. Journal of Evidence-Based Medicine. 3(3). 168–176. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026